Hologic, Inc. (NASDAQ:HOLX) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 5,028,000 shares, a drop of 15.9% from the May 30th total of 5,981,100 shares. Based on an average trading volume of 1,540,000 shares, the short-interest ratio is presently 3.3 days. Currently, 1.9% of the company’s shares are short sold.
Shares of NASDAQ:HOLX traded down $0.30 during trading on Friday, reaching $47.32. 1,379,703 shares of the company were exchanged, compared to its average volume of 1,768,642. The company has a market capitalization of $12.68 billion, a price-to-earnings ratio of 21.22, a PEG ratio of 2.21 and a beta of 0.72. The business’s fifty day simple moving average is $46.97. Hologic has a 12-month low of $37.47 and a 12-month high of $49.78. The company has a quick ratio of 1.02, a current ratio of 1.45 and a debt-to-equity ratio of 1.31.
Hologic (NASDAQ:HOLX) last issued its earnings results on Wednesday, May 1st. The medical equipment provider reported $0.58 EPS for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.01. The business had revenue of $818.40 million for the quarter, compared to analyst estimates of $806.99 million. Hologic had a negative net margin of 0.32% and a positive return on equity of 26.73%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company posted $0.53 earnings per share. On average, sell-side analysts expect that Hologic will post 2.42 EPS for the current fiscal year.
In related news, insider Peter J. Valenti III sold 4,545 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $44.07, for a total value of $200,298.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its holdings in Hologic by 9.6% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 92,228 shares of the medical equipment provider’s stock worth $3,791,000 after buying an additional 8,061 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Hologic by 0.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,166,835 shares of the medical equipment provider’s stock worth $89,051,000 after buying an additional 8,284 shares during the last quarter. Natixis Advisors L.P. boosted its holdings in Hologic by 18.0% during the fourth quarter. Natixis Advisors L.P. now owns 131,087 shares of the medical equipment provider’s stock worth $5,387,000 after buying an additional 19,982 shares during the last quarter. Kinneret Advisory LLC bought a new position in Hologic during the fourth quarter worth about $289,000. Finally, Geode Capital Management LLC boosted its holdings in Hologic by 5.3% during the fourth quarter. Geode Capital Management LLC now owns 3,805,329 shares of the medical equipment provider’s stock worth $156,146,000 after buying an additional 190,788 shares during the last quarter. Hedge funds and other institutional investors own 96.38% of the company’s stock.
Hologic Company Profile
Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Read More: What is the 52-week high/low?
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.